About: Jerzy Świerkot

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Jerzy Świerkot Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Polish rheumatologist and internist

Attributes	Values
rdf:type	Item
description	wetenschapper (nl) дослідник (uk) 研究者 (zh) Polish rheumatologist and internist (en) polski lekarz, reumatolog i internista (pl)
rdfs:label	Jerzy Świerkot (en) Jerzy Świerkot (pl)
skos:prefLabel	Jerzy Świerkot (en) Jerzy Świerkot (pl)
name	Jerzy Świerkot (en) Jerzy Świerkot (pl)
Polish scientist ID (deprecated)	wds:Q117235021-246a7e34-4d8b-585e-9106-c14ea748dbae
Polish scientist ID (deprecated)	87615
given name	wds:Q117235021-52CA30BB-D4F7-4CE7-A92F-8E675A940D32 wds:Q117235021-AD689FCD-0B23-4FD7-BF7E-C10A5475EF5B
given name	Piotr Jerzy
instance of	wds:Q117235021-66F487E7-16F6-476E-83F0-884BACBEE730
instance of	Homo sapiens
doctoral student	wds:Q117235021-4489F4E6-E860-496C-87B3-33D00481FF3F
doctoral student	Katarzyna Białowąs
skos:altLabel	Jerzy Piotr Świerkot (pl)
occupation	wds:Q117235021-5F1B3CF4-48FB-4383-80C4-C2295134317E wds:Q117235021-6A1A8829-E13A-42B5-A85D-9BB7209ED7C3
sex or gender	wds:Q117235021-bbbd70f4-4e54-13bf-6b7d-868f86cafdb3
academic degree	wds:Q117235021-1F931482-D2EB-4732-904B-0F36CE395FBB wds:Q117235021-27A23DE1-6CE0-4251-A68F-7EE9436FD79D
family name	wds:Q117235021-BCCAC78C-474D-44A4-99AB-6B018DB2F807
occupation	internist researcher
sex or gender	male
academic degree	doctorate habilitation
family name	Świerkot
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q117235021
is author of	Methotrexate in rheumatoid arthritis. Exogenous IL-2 controls the balance in Th1, Th17, and Treg cell distribution in patients with progressive rheumatoid arthritis treated with TNF-alpha inhibitors Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement Analysis of associations between polymorphisms within genes coding for tumour necrosis factor (TNF)-alpha and TNF receptors and responsiveness to TNF-alpha blockers in patients with rheumatoid arthritis Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. [The role of Th1, Th17, and Treg cells in the pathogenesis of rheumatoid arthritis including anti-inflammatory action of Th1 cytokines] Role of Porphyromonas gingivalis in rheumatoid arthritis and inflammatory spondyloarthropathies Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis. Systemic lupus erythematosus and human immunodeficiency virus infection IL-17A, IL-17F and IL-23R Gene Polymorphisms in Polish Patients with Rheumatoid Arthritis Application of (1)H NMR-based serum metabolomic studies for monitoring female patients with rheumatoid arthritis. Significance of Polymorphism and Expression of miR-146a and NFkB1 Genetic Variants in Patients with Rheumatoid Arthritis. Methotrexate treatment for rheumatoid arthritis in Poland: Retrospective analysis of patients in routine clinical practice. Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritis. [Behçet's disease--difficulty in diagnostic and management] [The role of diagnostic tests in the identification of Chlamydia trachomatis infection in reactive arthritis] [The importance of pharmacogenetic tests in evaluation of the effectiveness of methotrexate treatment in rheumatoid arthritis (part 2)] The role of diet in rheumatoid arthritis Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study. The Activity of JAK/STAT and NF-κB in Patients with Rheumatoid Arthritis. The role of microRNA-5196 in the pathogenesis of systemic sclerosis. Biosimilar switching - current state of knowledge Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis. Practical comments on the use of immunoglobulins Activity of JAK/STAT and NF-kB in patients with axial spondyloarthritis. Alterations in both the activatory and inhibitory potential of peripheral blood CD4+ T cells in rheumatoid arthritis patients correlate with disease progression The arthritic pathologies accompanying primary immunodeficiencies with antibody synthesis disturbances Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64. Polymorphisms within Genes Involved in Regulation of the NF-κB Pathway in Patients with Rheumatoid Arthritis. Autoantibody and metalloproteinase activity in early arthritis [Renal tubular dysfunction in patients with rheumatoid arthritis starting with low dose of methotrexate] Influence of CD94 and NKG2A variants on susceptibility to rheumatoid arthritis and efficacy of anti-TNF treatment. Cytokine profiles in axial spondyloarthritis Diagnostic and therapeutic problems in SARA syndrome (sexually acquired reactive arthritis) particularly considering the role of Chlamydia trachomatis Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients [The importance of pharmacogenetic tests in evaluation of the effectiveness of methotrexate treatment in rheumatoid arthritis (part 1)] [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part I. Tumor necrosis factor alpha inhibitors] [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part II. Tocilizumab, Abatacept, Rituximab--drugs characterised by a different mechanism of action than TNF-alpha inhibitors] [Lupus erythematosus or human immunodeficiency virus infection? Diagnostic problems in rheumatologic practice--two case reports] [Rheumatic disorders in diabetes mellitus] [Can non-steroidal anti-inflammatory drugs be improved?] Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis The importance of ultrasound examination in early arthritis Results from Polish Spondyloarthritis Initiative registry (PolSPI) - methodology and data from - the first year of observation The role of intravenous immunoglobulin in the treatment of rheumatic diseases in adults Biosimilars--opportunity or threat? [Tumors in rheumatic diseases].
is author of	wds:Q35132706-BB7DBDF3-F32A-43DB-851E-86B04A51D208 wds:Q49693642-4DC6834E-9CEF-4865-8BD0-62529C8D0C11 wds:Q43418320-44B84E2C-8D6D-4793-943B-4DBD6A75DC40 wds:Q55044448-DB2E8869-9EDA-416F-8713-DFE2D15367F2 wds:Q82455431-2AE15548-658D-4307-B70E-E62A2140FE0B wds:Q75186721-18FABC20-529B-496B-8552-4404D3581285 wds:Q83897815-E4ACF63C-DF34-4423-BD00-C15D80E78E2D wds:Q33396228-4982147D-76C6-460C-AE5A-C449FBB34EDC wds:Q37681485-2FE907FA-240A-4BF8-95EA-0DF04D3ABAD2 wds:Q46521131-246D10BE-D36A-47F5-82B7-99445479B788 wds:Q55381625-45BEA9AB-01BA-4F1F-8365-44465A63159C wds:Q58594045-C89906D4-B1C2-45F7-A0EF-7A92CBA122C3 wds:Q75186777-00A01C3C-E9A4-4FCB-BCCB-8B95913B16D7 wds:Q39608151-8550ABEF-C490-40C1-BF5F-F817D22D3AEF wds:Q37869007-67073B8D-BA73-46D8-AC13-651282F9F1E5 wds:Q61919255-AB21E63A-E96A-4208-BA6D-27C1375BBD79 wds:Q83897809-A7F02642-A38D-4D92-94A1-84CFD22B7E10

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 182 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software